ALZ-801 is a potent and orally available small-molecule beta-amyloid (Abeta) anti-oligomer and aggregation inhibitor, valine-conjugated proagent of Tramiprosate with substantially improved PK properties and gastrointestinal tolerability compared with the parent compound[1]. ALZ-801 is an advanced and markedly improved candidate for the treatment of alzheimers disease[2].
Molecular Weight:
238.30
Purity:
98.83
CAS Number:
[1034190-08-3]
Formula:
C8H18N2O4S
Target:
Amyloid-beta
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
